Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Zerit (stavudine) - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board

21 March 2011

Important Safety Information communication from Bristol-Myers Squibb Pharmaceuticals on restriction of the indication for Zerit (stavudine) Hard Capsules and Powder for Oral Solution.

Important Safety Information - Zerit

Date Printed: 20 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971